We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$77.6B
AUM Growth
+$5.19B
(+7.2%)
Cap. Flow
+$4.38B
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
15.11%
Holding
3,002
New
251
Increased
1,435
Reduced
1,132
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$243M |
| 3 |
Tesla
TSLA
|
+$188M |
| 4 |
Adobe
ADBE
|
+$159M |
| 5 |
Infosys
INFY
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$143M |
| 2 |
Cigna
CI
|
+$133M |
| 3 |
Delta Air Lines
DAL
|
+$121M |
| 4 |
Walt Disney
DIS
|
+$120M |
| 5 |
Cisco
CSCO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.8% |
| 2 | Financials | 15.9% |
| 3 | Healthcare | 13.33% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 11.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Absci
ABSI
$1.56B
| $38.3K | ﹤0.01% |
14,637
-13,800
| -49% | -$48.6K |
|
|
AGEN
2827
Agenus
AGEN
$295M
| $38K | ﹤0.01% |
13,882
-970
| -7% | -$3.59K |
|
2828
Accuray
ARAY
$35.9M
| $37.4K | ﹤0.01% |
+18,893
| New | +$35.7K |
|
2829
Dakota Gold
DC
$834M
| $36.7K | ﹤0.01% |
+16,676
| New | +$37.6K |
|
2830
Nerdy
NRDY
$95.1M
| $36.3K | ﹤0.01% |
+22,426
| New | +$27.8K |
|
|
BHR
2831
Braemar Hotels & Resorts
BHR
$139M
| $35K | ﹤0.01% |
11,653
+1,647
| +16% | +$5.33K |
|
2832
Puma Biotechnology
PBYI
$458M
| $33K | ﹤0.01% |
+10,817
| New | +$31.5K |
|
|
QIPT
2833
DELISTED
Quipt Home Medical
QIPT
| $32.4K | ﹤0.01% |
+10,618
| New | +$28.6K |
|
|
GCTS
2834
GCT Semiconductor Holding
GCTS
$191M
| $32.3K | ﹤0.01% |
13,862
-11,664
| -46% | -$29.4K |
|
|
NKLA
2835
DELISTED
Nikola Corporation Common Stock
NKLA
| $32K | ﹤0.01% |
26,906
-16,697
| -38% | -$47.7K |
|
|
URG
2836
Ur-Energy
URG
$556M
| $31K | ﹤0.01% |
26,979
+14,364
| +114% | +$17.7K |
|
|
FSP
2837
Franklin Street Properties
FSP
$46.2M
| $30.5K | ﹤0.01% |
16,681
-177,019
| -91% | -$323K |
|
2838
Rimini Street
RMNI
$449M
| $28.2K | ﹤0.01% |
+10,572
| New | +$21.6K |
|
2839
Tevogen Inc. Common Stock
TVGN
$27.4M
| $27.3K | ﹤0.01% |
531
+10
| +2% | +$652 |
|
|
AKYA
2840
DELISTED
Akoya BioSciences
AKYA
| $25.3K | ﹤0.01% |
+11,054
| New | +$29.3K |
|
2841
Century Therapeutics
IPSC
$364M
| $24.4K | ﹤0.01% |
24,204
+3,343
| +16% | +$4.55K |
|
2842
Precigen
PGEN
$2.47B
| $22.3K | ﹤0.01% |
19,934
+4,041
| +25% | +$3.45K |
|
2843
LanzaTech
LNZA
$67M
| $22.1K | ﹤0.01% |
+161
| New | +$24.2K |
|
|
NOTE
2844
DELISTED
FiscalNote
NOTE
| $21.9K | ﹤0.01% |
1,704
+727
| +74% | +$8.86K |
|
2845
GrafTech
EAF
$204M
| $21.2K | ﹤0.01% |
+1,226
| New | +$22.8K |
|
2846
Actinium Pharmaceuticals
ATNM
$24.7M
| $21K | ﹤0.01% |
16,704
-342,649
| -95% | -$532K |
|
2847
X4 Pharmaceuticals
XFOR
$434M
| $19.7K | ﹤0.01% |
895
-22,962
| -96% | -$366K |
|
2848
MarketWise
MKTW
$53.9M
| $17.2K | ﹤0.01% |
+1,519
| New | +$17K |
|
2849
System1
SST
$17.5M
| $16.4K | ﹤0.01% |
1,827
+447
| +32% | +$4.5K |
|
2850
Prelude Therapeutics
PRLD
$421M
| $15.9K | ﹤0.01% |
+12,493
| New | +$16.6K |
|
Similar funds
VGA
AQR Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, AQR Capital Management held 3,002 positions worth $77.6B, up 7.2% from $72.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $4.38B of net new capital in Q4 2024, opening 251 new positions and adding to 1,435 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $143M trimmed.
- AQR Capital Management's largest Q4 2024 buy was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
- AQR Capital Management added most to Apple in Q4 2024, an estimated $523M increase.
- AQR Capital Management's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $143M.
- AQR Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $5.41M.
- AQR Capital Management's ten largest holdings make up 15% of its $77.6B portfolio in Q4 2024.
- AQR Capital Management opened 251 new positions and closed 141 in Q4 2024.
- AQR Capital Management's portfolio value rose 7.2% quarter-over-quarter to $77.6B.
Based on AQR Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.